indazoles has been researched along with gs-5806 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, JW; DeVincenzo, JP; Farrell, E; Harrison, L; Jordan, R; Lambkin-Williams, R; Lewis, SA; Li, X; Lin, SL; Mackman, RL; McBride, S; O'Riordan, T; Ramanathan, S; Scaglioni-Weinlich, C; Toback, SL; Whitley, RJ; Xin, Y | 1 |
| Wright, PF | 1 |
| Babaoglu, K; Boojamra, C; Carey, A; Cihlar, T; Desai, M; Eisenberg, E; Gilbert, BE; Hayes, J; Hui, H; Iwata, Q; Jordan, R; Kinkade, A; Lee, G; Mackman, RL; Parrish, JP; Perron, M; Piedra, PA; Samuel, D; Sangi, M; Saunders, O; Siegel, D; Sperandio, D; Stray, K; Strickley, R; Theodore, D; Yang, H; Zhang, L | 1 |
| De Clercq, E | 1 |
| Anderson, ML; Behrens, NE; Carey, A; Chien, JW; Cihlar, T; Eisenberg, EJ; Gershwin, LJ; Jordan, R; Lewis, SA; Mackman, RL; McEligot, HA; Perron, M; Shao, M; Strickley, RG | 1 |
| Brendza, KM; Hung, M; Jordan, R; Liu, X; Mackman, R; Niedziela-Majka, A; Perron, M; Sakowicz, R; Samuel, D; Sperandio, D; Wong, JS; Xing, W | 1 |
| Cihlar, T; Eisenberg, E; Gilbert, BE; Jordan, R; Kinkade, A; Lee, G; Mackman, R; Perron, M; Piedra, PA; Sangi, M; Stray, K; Theodore, D; Toms, GL | 1 |
| Anderson, F; Chien, JW; Cihlar, T; DeVincenzo, J; Jordan, R; Lewis, SA; Miller, M; Perron, M; Perry, J; Porter, DP; Stray, K | 1 |
1 review(s) available for indazoles and gs-5806
| Article | Year |
|---|---|
Chemotherapy of respiratory syncytial virus infections: the final breakthrough.
Topics: Administration, Inhalation; Antiviral Agents; Humans; Indazoles; Pyrazoles; Respiratory Syncytial Virus Infections; Ribavirin; Sulfonamides; Treatment Outcome | 2015 |
4 trial(s) available for indazoles and gs-5806
| Article | Year |
|---|---|
Oral GS-5806 activity in a respiratory syncytial virus challenge study.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Area Under Curve; Double-Blind Method; Female; Humans; Indazoles; Male; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Severity of Illness Index; Sulfonamides; Viral Load; Young Adult | 2014 |
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study.
Topics: Administration, Oral; Animals; Antiviral Agents; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Indazoles; Macaca fascicularis; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Structure-Activity Relationship; Sulfonamides; Virus Internalization | 2015 |
Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
Topics: Animals; Antiviral Agents; Bronchiolitis; Cattle; Cattle Diseases; Cell Line; Cell Membrane; Double-Blind Method; Humans; Indazoles; Lung; Male; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Bovine; Respiratory Syncytial Virus, Human; Sulfonamides; Viral Load | 2015 |
Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
Topics: Adolescent; Adult; Amino Acid Substitution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Humans; Indazoles; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfonamides; Viral Fusion Protein Inhibitors; Viral Load; Young Adult | 2020 |
3 other study(ies) available for indazoles and gs-5806
| Article | Year |
|---|---|
Progress in the prevention and treatment of RSV infection.
Topics: Antiviral Agents; Female; Humans; Indazoles; Male; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfonamides | 2014 |
GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein.
Topics: Antiviral Agents; Indazoles; Protein Conformation; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Sulfonamides; Viral Proteins | 2015 |
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
Topics: Antiviral Agents; Bronchi; Cell Fusion; Cell Line; Drug Evaluation, Preclinical; Drug Resistance, Viral; Humans; Indazoles; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Sulfonamides; Virus Internalization | 2015 |